USPTO serial 88508440
GLUCEMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEVERLY, JOSETTE MICHELLE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GLUCEMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua G. Gigger
Joshua G. Gigger STOEL RIVES LLP201 South Main Street, Suite 1200SALT LAKE CITY, UT 84111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diabetes diagnostic test kits comprised of diagnostic reagents, diagnostic test cartridges, control chemical solutions and assays for use in physician's offices; and diabetes diagnostic test kits comprised of diagnostic reagents, diagnostic test cartridges, control chemical solutions and assays for home use | ACTIVE | — |
| 010 | Medical test kits consisting of a specimen collection card for diabetes diagnosis and monitoring and also test forms, mailing materials and user information inserts sold therewith; blood collection kit comprised of a blood collection card; medical test kits for diabetes diagnosis and monitoring; and diabetic diagnostic medical devices | ACTIVE | — |
| 042 | Medical laboratory services, clinical laboratory services, reference laboratory services and diagnostic laboratory services; and laboratory services, namely, analysis of oral fluid and blood samples for diabetes | ACTIVE | — |
| 044 | Providing information in the field of diabetes; providing an internet website for medical professionals featuring medical information in the fields of diabetes diagnosis, monitoring and treatment; medical testing for diagnostic and treatment purposes in the field of diabetes; medical diagnostic testing, reporting and monitoring services; and medical information services, namely, reporting of testing results directly to patients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Diabetomics, Inc.
- Other trademarks owned by Diabetomics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GLUCEMA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 5, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 11, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 10, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 10, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 3, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 15, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 13, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 13, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 13, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 5, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 5, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 10, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 8, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 8, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 2, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 30, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 30, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 30, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 5, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 22, 2020 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 9, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 23, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 26, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2019 | NWAP | NEW APPLICATION ENTERED | — |